Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

3 of 3 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT02341287Not ApplicableTerminated

Temperature Manipulating Gloves for the Treatment of Insomnia

Role: collaborator

NCT03054064Not ApplicableCompleted

Evaluating the Indego Exoskeleton for Persons With Hemiplegia Due to CVA

Role: lead

NCT02793635Not ApplicableCompleted

Indego Exoskeleton After SCI

Role: lead

NCT02202538Not ApplicableCompleted

Indego® Exoskeleton; Assessing Mobility for Persons With Spinal Cord Injury (SCI).

Role: lead

All 4 trials loaded